BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+4.07%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$155M
AUM Growth
+$155M
(+5.5%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
6.61%
Top 10 Holdings %
Top 10 Hldgs %
70.21%
Holding
70
New
6
Increased
8
Reduced
5
Closed
3
Top Buys
1 |
Elutia
ELUT
|
$8.06M |
2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$1.75M |
3 |
Biodesix
BDSX
|
$782K |
4 |
Neurocrine Biosciences
NBIX
|
$767K |
5 |
TSVT
2seventy bio
TSVT
|
$718K |
Top Sells
1 |
Bristol-Myers Squibb
BMY
|
$1.87M |
2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.84M |
3 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$410K |
4 |
Vanda Pharmaceuticals
VNDA
|
$314K |
5 |
Arcutis Biotherapeutics
ARQT
|
$215K |
Sector Composition
1 | Healthcare | 96.09% |
2 | Energy | 2.08% |
3 | Consumer Staples | 0.21% |